Equity Overview
Price & Market Data
Price: $21.37
Daily Change: +$0.37 / 1.73%
Daily Range: $20.56 - $21.73
Market Cap: $399,966,912
Daily Volume: 248,780
Performance Metrics
1 Week: -5.90%
1 Month: 13.43%
3 Months: 16.90%
6 Months: -11.25%
1 Year: -30.70%
YTD: 2.44%
Company Details
Employees: 51
Sector: Commercial services
Industry: Miscellaneous commercial services
Country:
Details
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.